New norepinephrine-depleting agents. Beta-hydroxyphenethylguanidine and related compounds.
D000311:Adrenal Glands / Q000032:analysis; D000818:Animals; D001763:Blepharoptosis / Q000139:chemically induced; D001923:Brain Chemistry; D002415:Cats; D005470:Fluorometry; D006145:Guanethidine / Q000494:pharmacology; D006146:Guanidines / Q000494:pharmacology*; D006168:Guinea Pigs; D051379:Mice; D009206:Myocardium / Q000032:analysis*; D009541:Nictitating Membrane / Q000187:drug effects; D009638:Norepinephrine / Q000032:analysis*; D011817:Rabbits; D051381:Rats; D013154:Spleen / Q000032:analysis; D013564:Sympathetic Nervous System / Q000187:drug effects
D006146:Guanidines; D009638:Norepinephrine; D006145:Guanethidine